Management of Pediatric and Adolescent Type 2 Diabetes

Overview

Journal Int J Pediatr

Publisher Wiley

Specialty Pediatrics

Date 2013 Nov 22

PMID 24260037

Citations 7

Authors

M Constantine Samaan

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes (T2D) was an adult disease until recently, but the rising rates of obesity around the world have resulted in a younger age at presentation. Children who have T2D have several comorbidities and complications reminiscent of adult diabetes, but these are appearing in teens instead of midlife. In this review, we discuss the clinical presentation and management options for youth with T2D. We discuss the elements of lifestyle intervention programs and allude to pharmacotherapeutic options used in the treatment of T2D youth. We also discuss comorbidities and complications seen in T2D in children and adolescents.

Citing Articles

Global trends and hotspots of type 2 diabetes in children and adolescents: A bibliometric study and visualization analysis.

Zhang F, Li H, Yu X, Song Y, Ren Y, Qian X World J Diabetes. 2025; 16(1):96032.

PMID: 39817223 PMC: 11718446. DOI: 10.4239/wjd.v16.i1.96032.

Early-Onset Type 2 Diabetes Mellitus.

Sunny A Cureus. 2021; 13(8):e17578.

PMID: 34513530 PMC: 8405399. DOI: 10.7759/cureus.17578.

Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop.

Barrett J, Bucci-Rechtweg C, Cheung S, Gamalo-Siebers M, Haertter S, Karres J Clin Pharmacol Ther. 2020; 108(1):29-39.

PMID: 32017043 PMC: 7383960. DOI: 10.1002/cpt.1805.

The prevalence of undiagnosed Prediabetes/type 2 diabetes, prehypertension/hypertension and obesity among ethnic groups of adolescents in Western Canada.

Spurr S, Bally J, Bullin C, Allan D, McNair E BMC Pediatr. 2020; 20(1):31.

PMID: 31973728 PMC: 6979336. DOI: 10.1186/s12887-020-1924-6.

A survey on glycemic control rate of type 2 diabetes mellitus with different therapies and patients' satisfaction in China.

Dong Q, Huang J, Liu S, Yang L, Li J, Li B Patient Prefer Adherence. 2019; 13:1303-1310.

PMID: 31534317 PMC: 6682321. DOI: 10.2147/PPA.S198908.

References

Foretz M, Hebrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G . Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010; 120(7):2355-69. PMC: 2898585. DOI: 10.1172/JCI40671. View

Hannon T, Rao G, Arslanian S . Childhood obesity and type 2 diabetes mellitus. Pediatrics. 2005; 116(2):473-80. DOI: 10.1542/peds.2004-2536. View

Hogg R, Furth S, Lemley K, Portman R, Schwartz G, Coresh J . National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003; 111(6 Pt 1):1416-21. DOI: 10.1542/peds.111.6.1416. View

Jones K, Arslanian S, Peterokova V, Park J, Tomlinson M . Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2002; 25(1):89-94. DOI: 10.2337/diacare.25.1.89. View

Flint A, Arslanian S . Treatment of type 2 diabetes in youth. Diabetes Care. 2011; 34 Suppl 2:S177-83. PMC: 3632158. DOI: 10.2337/dc11-s215. View

Rosenbloom A, Silverstein J, Amemiya S, Zeitler P, Klingensmith G . Type 2 diabetes in children and adolescents. Pediatr Diabetes. 2009; 10 Suppl 12:17-32. DOI: 10.1111/j.1399-5448.2009.00584.x. View

Berenson G, Srnivasan S . Cardiovascular risk factors in youth with implications for aging: the Bogalusa Heart Study. Neurobiol Aging. 2005; 26(3):303-7. DOI: 10.1016/j.neurobiolaging.2004.05.009. View

Ehrmann D . Polycystic ovary syndrome. N Engl J Med. 2005; 352(12):1223-36. DOI: 10.1056/NEJMra041536. View

Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A . Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care. 1997; 20(5):844-7. DOI: 10.2337/diacare.20.5.844. View

10.

Bretzel R, Nuber U, Landgraf W, Owens D, Bradley C, Linn T . Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. Lancet. 2008; 371(9618):1073-84. DOI: 10.1016/S0140-6736(08)60485-7. View

11.

Nandagopal R, Brown R, Rother K . Resolution of type 2 diabetes following bariatric surgery: implications for adults and adolescents. Diabetes Technol Ther. 2010; 12(8):671-7. PMC: 2936261. DOI: 10.1089/dia.2010.0037. View

12.

Weigensberg M, Goran M . Type 2 diabetes in children and adolescents. Lancet. 2009; 373(9677):1743-4. DOI: 10.1016/S0140-6736(09)60961-2. View

13.

Nicandri K, Hoeger K . Diagnosis and treatment of polycystic ovarian syndrome in adolescents. Curr Opin Endocrinol Diabetes Obes. 2012; 19(6):497-504. DOI: 10.1097/MED.0b013e32835a1a03. View

14.

Reinehr T, Schober E, Roth C, Wiegand S, Holl R . Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers. Horm Res. 2007; 69(2):107-13. DOI: 10.1159/000111814. View

15.

Martin J, Deacon C, Gorrell M, Prins J . Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experience. Intern Med J. 2011; 41(4):299-307. DOI: 10.1111/j.1445-5994.2011.02439.x. View

16.

Maahs D, Snively B, Bell R, Dolan L, Hirsch I, Imperatore G . Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care. 2007; 30(10):2593-8. DOI: 10.2337/dc07-0450. View

17.

Sirtori C, Pasik C . Re-evaluation of a biguanide, metformin: mechanism of action and tolerability. Pharmacol Res. 1994; 30(3):187-228. DOI: 10.1016/1043-6618(94)80104-5. View

18.

Kotronen A, Yki-Jarvinen H . Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2007; 28(1):27-38. DOI: 10.1161/ATVBAHA.107.147538. View

19.

Silverstein J, Rosenbloom A . Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab. 2001; 13 Suppl 6:1403-9. DOI: 10.1515/jpem-2000-s614. View

20.

Bikman B, Zheng D, Kane D, Anderson E, Woodlief T, Price J . Metformin Improves Insulin Signaling in Obese Rats via Reduced IKKbeta Action in a Fiber-Type Specific Manner. J Obes. 2010; 2010. PMC: 2925476. DOI: 10.1155/2010/970865. View